Survival of multiple sclerosis in Finland between 1964 and 1993

Abstract

The long-term survival of multiple sclerosis (MS) was studied during 1964-1993 in a cohort of 1614 patients in Finland. Survival to death from the initial MS symptoms was analysed by the life-table method, separately for MS related and all causes of deaths. Survival at 40 years was 64% for MS deaths and 53% for all deaths. Higher proportions of violent deaths and neoplasms were observed among MS patients as compared to the general population, whereas the proportion of cardiovascular causes of death was low. MS-related causes accounted for 70% of the recorded 219 deaths. Favourable survival in MS was associated with relapsing-remitting disease course, age at onset below 30 years and optic neuritis or other sensory symptoms at presentation. We were unable to show any significant effect due to calendar time of diagnosis or gender, as the risk of men was similar (risk ratio [RR]=1.1, confidence interval [CI] 0.8-1.6) as compared to women.

Keywords

causes of death course Cox models multiple sclerosis prognostic factors survival analysis

Get full access to this article

View all access options for this article.

References

Brønnum-Hansen H , Koch-Henriksen N , Hyllested K. Survival of patients with multiple sclerosis in Denmark: a nationwide, long-term epidemiologic survey . Neurology 1994; 44: 1901-1907 .

Midgaard R , Albrektsen G , Riise T , et al. Prognostic factors for survival in multiple sclerosis: a longitudinal, population based study in More and Romsdal, Norway . J Neurol Neurosurg Psychiatry 1995; 58: 417-421 .

Wallin MT , Page WF , Kurtzke JF. Epidemiology of multiple sclerosis in US veterans: VIII. Long-term survival after onset of multiple sclerosis . Brain 2000; 123: 1677-1687 .

Wynn DR , Rodriquez M , O’Fallon M , Kurland LT. A reappraisal of the epidemiology of multiple sclerosis in Olmstead County, Minnesota . Neurology 1990; 40: 780-786 .

Phadke JG. Survival pattern and cause of death in patients with multiplesclerosis:results from anepidemiologicalsurveyinnorth east Scotland . J Neurol Neurosurg Psychiatry 1987; 50: 523-531 .

Poser S , Bauer HJ , Poser W. Prognosis of multiple sclerosis. Results from an epidemiological area in Germany . Acta Neurol Scand 1982; 65: 347-354 .

Sadovnick AD , Ebers GC , Wilson RW , Paty DW. Life expectancy in patients attending multiple sclerosis clinics . Neurology 1992; 42: 991-994 .

Koch-Henriksen N , Bronnum-Hansen H , Stenager E. Underlying cause of death in Danish patients with multiple sclerosis: results from the Danish Multiple Sclerosis Registry . J Neurol Neurosurg Psychiatry 1998; 65: 56-59 .

Sadovnick AD , Eisen RN , Ebers GC , Paty DW. Cause of death in patients attending multiple sclerosis clinics . Neurology 1991; 41: 1193-1196 .

10.

Weinshenker BG , Ebers GC. The natural history of multiple sclerosis . Can J Neurol Sci 1987; 14: 255-261 .

11.

Weinshenker BG , Rice GPA , Noseworthy JH , et al. The natural history of multiple sclerosis: a geographically based study: 3. Multivariate analysis of predictive factors and models of outcome . Brain 1991; 114: 1045-1056 .

12.

Wikström J , Palo J. Studies on the clustering of multiple sclerosis in Finland: II. Microepidemiology in one high-risk county with special reference to familial cases . Acta Neurol Scand 1975; 51: 173-183 .

13.

Kinnunen E , Wikström J , Porras J , Palo J. The epidemiology of multiple sclerosis in Finland: increase of prevalence and stability of high-risk areas . Acta Neurol Scand 1983; 67: 255-262 .

14.

Poser CM , Paty DW , Scheinberg L , et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols . Ann Neurol 1983; 13: 227-231 .

15.

Sumelahti ML , Tienari PJ , Wikström J , et al. Regional and temporal variation in the incidence of multiple sclerosis in Finland 1979 - 1993 . Neuroepidemiology 2000; 19: 67-75 .

16.

Central Statistical Office of Finland . Causes of death 1988 . Health 1990: 4.

17.

Kurtzke JF , Auth TL , Beebe GW , et al. Survival in multiple sclerosis . Trans Am Neurol Assoc 1969; 94: 134-139 .

18.

Runmarker B , Andersen O. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up . Brain 1993; 116: 117-134 .

19.

Weinshenker BG , Bass B , Rice GPA , et al. The natural history of multiple sclerosis: a geographically based study: 1. Clinical course and disability . Brain 1989; 112: 133-146 .

20.

Poser S , Kurtzke JF , Poser W , Schlaf G. Survival in multiple sclerosis . J Clin Epidemiol 1989; 42: 159-168 .

21.

World Health Statistics Annual 1993. Geneva: World Health Organization , 1994.

22.

Phadke JG. Clinical aspects of multiple sclerosis in north-east Scotland with particular reference to its course and prognosis . Brain 1990; 113: 1597-1628 .

23.

Riise T , Gronning M , Aarli JA , et al. Prognostic factors for life expectancy in multiple sclerosis analysed by Cox-models . J Clin Epidemiol 1998; 41: 1031-1036 .

24.

Sumelahti M-L , Tienari PJ , Wikström J , et al. Increasing prevalence of multiple sclerosis in Finland . Acta Neurol Scand 2001; 103: 1-6 .

25.

Miller DH , Hornabrook RW , Purdie G. The natural history of multiple sclerosis: a regional study with some longitudinal data . J Neurol Neurosurg Psychiatry 1992; 55: 341-346 .